CRISPR/Cas9-mediated genome editing in Epstein-Barr virus-transformed lymphoblastoid B-cell lines

Current Protocols in Molecular Biology

Volumn 2018, Issue , 2018, Pages 31.12.1-31.12.23

  Jiang, Sizun ^a,b,c   Wang, Liang Wei ^a,b   Walsh, Michael J ^a,b   Trudeau, Stephen J ^b   Gerdt, Catherine ^b   Zhao, Bo ^b   Gewurz, Benjamin E ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Burkitt lymphoma; CRISPR; Enhancer; Epstein Barr virus; Genome editing; Lymphoblastoid

Indexed keywords

GREEN FLUORESCENT PROTEIN; GUIDE RNA; RIBONUCLEOPROTEIN; SINGLE GUIDE RNA; UNCLASSIFIED DRUG;

ARTICLE; B-LYMPHOBLASTOID CELL LINE; CONFOCAL MICROSCOPY; CRISPR-CAS9 SYSTEM; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EDITING; GENE LIBRARY; GENETIC ANALYSIS; HUMAN; IMMUNOBLOTTING; INCUBATION TIME; LIMIT OF QUANTITATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STREPTOCOCCUS PYOGENES; BURKITT LYMPHOMA; CELL CULTURE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CRISPR CAS SYSTEM; GENETIC TRANSFORMATION; GENETICS; PROCEDURES; VIROLOGY;

BURKITT LYMPHOMA; CELLS, CULTURED; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; GENE EDITING; HERPESVIRUS 4, HUMAN; HUMANS; RNA, GUIDE; TRANSFORMATION, GENETIC;

EID: 85042097534     PISSN: 19343639     EISSN: 19343647     Source Type: Journal    
DOI: 10.1002/cpmb.51     Document Type: Article

References (37)

1. Barrangou, R., & Horvath, P. (2017). A decade of discovery: CRISPR functions and applications. Nature Microbiology, 2, 17092. doi: 10.1038/nmicrobiol.2017.92
2. Benchling [Biology Software]. (2017)
3. Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014). Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Research, 42(22), e168-e168. doi: 10.1093/nar/gku936
4. Canver, M. C., Bauer, D. E., Dass, A., Yien, Y. Y., Chung, J., Masuda, T., Orkin, S. H. (2017). Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells. Journal of Biological Chemistry, 292(6), 2556. doi: 10.1074/jbc.A114.564625
5. Canver, M. C., Smith, E. C., Sher, F., Pinello, L., Sanjana, N. E., Shalem, O., Bauer, D. E. (2015). BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature, 527(7577), 192-197. doi: 10.1038/nature15521. Retrieved from https://www.nature.com/nature/journal/v527/n7577/abs/nature15521.htmlsupplementary-information
6. Choy, E., Yelensky, R., Bonakdar, S., Plenge, R. M., Saxena, R., De Jager, P. L., Altshuler, D. (2008). Genetic analysis of human traits in vitro: Drug response and gene expression in lymphoblastoid cell lines. PLoS Genetics, 4(11), e1000287. doi: 10.1371/journal.pgen.1000287
7. Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Zhang, F. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science, 339(6121), 819-823. doi: 10.1126/science.1231143
8. Desjardins, P. and Conklin, D. S. 2011. Microvolume Quantitation of Nucleic Acids. Current Protocols in Molecular Biology. 93, 3J:A.3J.1-A.3J.16
9. Diao, Y., Fang, R., Li, B., Meng, Z., Yu, J., Qiu, Y., Ren, B. (2017). A tiling-deletion-based genetic screen for cis-regulatory element identification in mammalian cells. Nature Methods, 14(6), 629-635. doi: 10.1038/nmeth.4264
10. Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Root, D. E. (2016). Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nature Biotechnology, 34(2), 184-191. doi: 10.1038/nbt.3437. Retrieved from https://www.nature.com/nbt/journal/v34/n2/abs/nbt.3437.html-supplementa ry-information
11. Doench, J. G., Hartenian, E., Graham, D. B., Tothova, Z., Hegde, M., Smith, I., Root, D. E. (2014). Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nature Biotechnology, 32(12), 1262-1267. doi: 10.1038/nbt.3026. Retrieved from https://www.nature.com/nbt/journal/v32/n12/abs/nbt.3026.html-supplementary-infor mation
12. Gallagher, S. R. (2011). Quantitation of DNA and RNA with Absorption and Fluorescence Spectroscopy. Current Protocols in Molecular Biology. 93, 3D:A.3D.1-A.3D.14
13. Greenfeld, H., Takasaki, K., Walsh, M. J., Ersing, I., Bernhardt, K., Ma, Y., Gewurz, B. E. (2015). TRAF1 Coordinates polyubiquitin signaling to enhance Epstein-Barr Virus LMP1-mediated growth and survival pathway activation. PLoS Pathogens, 11(5), e1004890. doi: 10.1371/journal.ppat.1004890
14. Hille, F., & Charpentier, E. (2016). CRISPR-Cas: Biology, mechanisms and relevance. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 371(1707). doi: 10.1098/rstb.2015.0496
15. Hsu, P. D., Lander, E. S., & Zhang, F. (2014). Development and applications of CRISPR-Cas9 for genome engineering. Cell, 157(6), 1262-1278. doi: 10.1016/j.cell.2014.05 .010
16. The International HapMap Project. (2003). Nature, 426(6968), 789-796. REtrieved from https://www.nature.com/nature/journal/v426/n6968/suppinfo/nature02168_S1.html. doi: 10.1038/nature02168
17. Jiang, S., Zhou, H., Liang, J., Gerdt, C., Wang, C., Ke, L., Zhao, B. (2017). 3D genome landscape of Epstein-Barr Virus oncoproteins and virus activated NF-B in lymphoblastoid cells. Cell Host & Microbe, Accepted). 17, 205-216. doi: 10.1016/j.chom.2014.12.013
18. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816-821. doi: 10.1126/science. 1225829
19. Kieff, E., & Rickinson, A. (2007). Epstein-Barr Virus and Its Replication. In P. Howley & D. Knipe (Eds.), Fields Virology (pp. 2603-2654). Philadelphia: Lippincott Williams & Wilkins
20. Kim, S., Kim, D., Cho, S.W., Kim, J., & Kim, J. S. (2014). Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Research, 24(6), 1012-1019. doi: 10.1101/gr.171322 .113
21. Korkmaz, G., Lopes, R., Ugalde, A. P., Nevedomskaya, E., Han, R., Myacheva, K., Agami, R. (2016). Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9. Nature Biotechnology, 34(2), 192-198. doi: 10.1038/nbt.3450. Retrieved from https://www.nature .com/nbt/journal/v34/n2/abs/nbt.3450.htmlsupplementary-information
22. Landt, S. G., Marinov, G. K., Kundaje, A., Kheradpour, P., Pauli, F., Batzoglou, S., Snyder, M. (2012). ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Research, 22(9), 1813-1831. doi: 10.1101/gr.136184.111
23. Ma, Y., Walsh, M. J., Bernhardt, K., Ashbaugh, C. W., Trudeau, S. J., Ashbaugh, I. Y., Gewurz, B. E. (2017). CRISPR/Cas9 screens reveal Epstein-Barr Virus-transformed B cell host dependency factors. Cell Host&Microbe, 21(5), 580-591. e587
24. Mali, P.,Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Church, G.M. (2013). RNAguided human genome engineering via Cas9. Science, 339(6121), 823-826. doi: 10.1126/science. 1232033
25. Ni, D., Xu, P., & Gallagher, S. (2016). Immunoblotting and immunodetection. Current Protocols in Molecular Biology/Edited by Frederick M. Ausubel, 114, 10.8.1-10.8.37. doi: 10.1002/0471142727.mb1008s114
26. Ohashi, M., Holthaus, A. M., Calderwood, M. A., Lai, C. Y., Krastins, B., Sarracino, D., & Johannsen, E. (2015). The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth. PLoS Pathogens, 11(4), e1004822. doi: 10.1371/journal.ppat.1004822
27. Pattengale, P., Smith, R., & Gerber, P. (1973). Selective transformation of B lymphocytes by E.B. virus. The Lancet, 302(7820), 93-94. doi: https://doi.org/10.1016/S0140-6736(73) 93286-8
28. Puschnik, A. S., Majzoub, K., Ooi, Y. S., & Carette, J. E. (2017). A CRISPR toolbox to study virus-host interactions. Nature Reviews. Microbiology, 15(6), 351-364. doi: 10.1038/nrmicro.2017.29
29. Sander, J. D., & Joung, J. K. (2014). CRISPR-Cas systems for editing, regulating and targeting genomes. Nature Biotechnology, 32(4), 347-355. doi: 10.1038/nbt.2842. Retrieved from https://www.nature.com/nbt/journal/v32/n4/abs/nbt.2842.html-supplementary-information
30. Schumann, K., Lin, S., Boyer, E., Simeonov, D. R., Subramaniam, M., Gate, R. E., Marson, A. (2015). Generation of knockin primary human T cells using Cas9 ribonucleoproteins. Proceedings of the National Academy of Sciences, 112(33), 10437-10442. doi: 10.1073/pnas.1512503112
31. The Genomes Project,C. (2015).Aglobal reference for human genetic variation. Nature, 526(7571), 68-74. doi: 10.1038/nature15393. Retrieved from https://www.nature.com/nature/journal/v526/n7571/abs/nature15393.html-supplement ary-information
32. Uphoff, C. C. and Drexler, H. G. 2014a. Detection of Mycoplasma Contamination in Cell Cultures. Current Protocols in Molecular Biology. 106, 28.4:28.4.1-28.4.14
33. Uphoff, C. C. andDrexler,H.G. 2014b. Eradication of Mycoplasma Contaminations from Cell Cultures. Current Protocols in Molecular Biology. 106, 28.5:28.5.1-28.5.12
34. Vidigal, J. A., & Ventura, A. (2015). Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries. Nature Communications, 6. doi: 10.1038/ncomms9083
35. Voytas, D. (2000). Agarose Gel Electrophoresis. Current Protocols in Molecular Biology, 51, II:2.5A:2.5A.1-2.5A.9
36. Wright, A. V., Nunez, J. K., & Doudna, J. A. (2016). Biology and applications of CRISPR systems: Harnessing nature's toolbox for genome engineering. Cell, 164(1-2), 29-44. doi: 10.1016/j.cell.2015.12.035
37. Zhu, S., Li, W., Liu, J., Chen, C.-H., Liao, Q., Xu, P., Wei, W. (2016). Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nature Biotechnology, 34(12), 1279-1286. doi: 10.1038/nbt.3715. Retrieved from https://www.nature.com/nbt/journal/v34/n12/abs/nbt.3715.html-supplementaryinformation